Articles dans des revues avec comité de lecture (129)
  1. 71. Alberti, L., Proverbio, M. C., Costagliola, S., Romoli, R., Boldrighini, B., Vigone, M. C., Weber, G., Chiumello, G., Beck-Peccoz, P., & Persani, L. (2002). Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. The Journal of clinical endocrinology and metabolism, 87(6), 2549-2555.
  2. 72. Smits, G., Govaerts, C., Nubourgh, I., Pardo, L., Vassart, G., & Costagliola, S. (2002). Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molecular endocrinology, 16(4), 722-735.
  3. 73. Vlaeminck-Guillem, V., Ho, S. C., Rodien, P., Vassart, G., & Costagliola, S. (2002). Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Molecular endocrinology, 16(4), 736-746. doi:10.1210/me.16.4.736
  4. 74. Claeysen, S., Govaerts, C., Lefort, A., Van Sande, J., Costagliola, S., Pardo, L., & Vassart, G. (2002). A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist. FEBS letters, 517(1-3), 195-200. doi:10.1016/S0014-5793(02)02620-0
  5. 75. Gérard, A.-C., Many, M.-C., Daumerie, C., Costagliola, S., Miot, F., DeVijlder, J. J. M., Colin, I. M., & Denef, J. F. (2002). Structural changes in the angiofollicular units between active and hypofunctioning follicles align with differences in the epithelial expression of newly discovered proteins involved in iodine transport and organification. The Journal of clinical endocrinology and metabolism, 87(3), 1291-1299.
  6. 76. Costagliola, S., Panneels, V., Bonomi, M., Koch, J., Many, M.-C., Smits, G., & Vassart, G. (2002). Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO journal, 21(4), 504-513. doi:10.1093/emboj/21.4.504
  7. 77. Daumerie, C., Ludgate, M., Costagliola, S., & Many, M.-C. (2002). Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. European journal of endocrinology, 146(1), 35-38.
  8. 78. Vlaeminck-Guillem, V., Vassart, G., & Costagliola, S. (2002). Un modèle d’activation du récepteur de la TSH. MS. Médecine sciences, 18(12), 1184-1186. doi:10.1051/medsci/200218121184
  9. 79. Alberti, L., Proverbio, M. C., Costagliola, S., Weber, G., Beck-Peccoz, P., Chiumello, G., & Persani, L. (2001). A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. European journal of endocrinology, 145(3), 249-254.
  10. 80. Cornelis, S., Uttenweiler-Joseph, S., Panneels, V., Vassart, G., & Costagliola, S. (2001). Purification and characterization of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor. Biochemistry, 40(33), 9860-9869. doi:10.1021/bi0107389
  11. 81. Ho, S. C., Van Sande, J., Lefort, A., Vassart, G., & Costagliola, S. (2001). Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology, 142(7), 2760-2767. doi:10.1210/en.142.7.2760
  12. 82. Govaerts, C., Lefort, A., Costagliola, S., Wodak, S., Ballesteros, J. A., Van Sande, J., Pardo, L., & Vassart, G. (2001). A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. The Journal of biological chemistry, 276(25), 22991-22999. doi:10.1074/jbc.M102244200
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>